Vynleads Stock Price, News & Analysis
Company Description
Vynleads Inc. develops technology-enabled wellness programs for chronic, lifestyle-driven conditions. The company trades on the OTCQB under the symbol VYND and is building a consumer wellness platform that translates lifestyle medicine principles into structured daily routines. Its work centers on condition-aware programs that combine digital guidance, AI-powered coaching, community support, and habit formation tools for users managing metabolic health goals.
The company’s flagship program is Done With Diabetes™, a mobile-first digital wellness app designed for adults with type 2 diabetes, prediabetes, and related metabolic health objectives. The app organizes behavior change around an 8-week Success Blueprint and adds ongoing support through the Dr. Smith AI Wellness Coach, AI Agent-powered community features, gamification, and an AI-powered Lifetime Wellness Mode. The platform is designed to provide repeatable daily structure outside the clinical setting, where food choices, movement, consistency, and lifestyle habits affect metabolic wellness.
Vynleads has described Done With (DWX) as its broader Lifestyle Blueprint technology platform. DWX is intended to support condition-specific wellness programs that convert evidence-informed guidance into routines consumers can follow over time. Done With Diabetes serves as the foundation for that platform, with the company positioning the model for additional health domains where chronic conditions are influenced by habits and daily adherence.
The company’s commercial model includes subscriptions to the Done With Diabetes app. This structure links Vynleads’ wellness content, AI coaching, and community engagement features to a recurring consumer software model rather than a one-time product sale. The company’s public profile is therefore centered on digital health, metabolic wellness, lifestyle medicine, AI-enabled coaching, and condition-specific consumer wellness programs.
Stock Performance
Vynleads (VYND) stock last traded at $0.4300. Over the past 12 months, the stock has lost 14.0%. At a market capitalization of $7.9M, VYND is classified as a micro-cap stock with approximately 18.3M shares outstanding.
VYND Rankings
Latest News
Vynleads has 2 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. Key topics include AI. View all VYND news →
SEC Filings
Vynleads has filed 3 recent SEC filings, including 1 Form NT 10-Q, 1 Form 10-K, 1 Form 10-Q. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VYND SEC filings →
Financial Highlights
operating income reached -$247K, and net income was -$255K. Diluted earnings per share stood at $-0.01. The company generated -$109K in operating cash flow. With a current ratio of 0.13, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
VYND Company Profile & Sector Positioning
Vynleads (VYND) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.